Faslodex (fulvestrant)

pCPA File Number: 20989
Negotiation Status:
Concluded without agreement
Indication(s):
Breast Cancer, Locally Advanced or Metastatic
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CDA-AMC Project Number:
PC0110-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: